• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease.

作者信息

Eidelman Rachel S, Lamas Gervasio A, Hennekens Charles H

机构信息

Mount Sinai Medical Center, Cardiology Research, 4300 Alton Rd, Suite 207A, Miami Beach, FL 33140, USA.

出版信息

Arch Intern Med. 2002 Oct 14;162(18):2033-6. doi: 10.1001/archinte.162.18.2033.

DOI:10.1001/archinte.162.18.2033
PMID:12374510
Abstract
摘要

相似文献

1
The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease.
Arch Intern Med. 2002 Oct 14;162(18):2033-6. doi: 10.1001/archinte.162.18.2033.
2
State-of-the-art update and review: clinical trials of lipid-lowering agents.最新进展与综述：降脂药物的临床试验
Am J Cardiol. 1998 Dec 17;82(12A):3U-17U; discussion 39U-41U. doi: 10.1016/s0002-9149(98)00957-6.
3
[Treatment of high blood cholesterol in patients with coronary heart disease].[冠心病患者高血胆固醇的治疗]
Nihon Rinsho. 2003 Apr;61 Suppl 4:675-81.
4
Improving health outcomes without increasing costs: maximizing the full potential of lipid reduction therapy in the primary and secondary prevention of coronary heart disease.在不增加成本的情况下改善健康结局：在冠心病一级和二级预防中充分发挥降脂治疗的全部潜力。
Curr Opin Lipidol. 1997 Dec;8(6):369-74. doi: 10.1097/00041433-199712000-00008.
5
Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.医学降脂治疗：当前证据、正在进行的试验及未来发展
Drugs. 2004;64(11):1181-96. doi: 10.2165/00003495-200464110-00003.
6
Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?高胆固醇血症。降脂对老年患者是否值得？
Geriatrics. 2000 May;55(5):22-8.
7
Cholesterol management in theory and practice.胆固醇管理的理论与实践
Circulation. 1997 Dec 16;96(12):4424-30. doi: 10.1161/01.cir.96.12.4424.
8
Economic implications of lipid-lowering trials: current considerations in selecting a statin.降脂试验的经济影响：选择他汀类药物的当前考量因素
Am J Cardiol. 1998 Sep 24;82(6A):26M-31M. doi: 10.1016/s0002-9149(98)00594-3.
9
Underutilization of lipid-lowering therapy in coronary artery disease.
Arch Intern Med. 2000 Sep 25;160(17):2683-4. doi: 10.1001/archinte.160.17.2683.
10
Statin therapy in older persons: pertinent issues.
Arch Intern Med. 2002 Jun 24;162(12):1329-31. doi: 10.1001/archinte.162.12.1329.

引用本文的文献

1
Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus.他汀类药物剂量、类别及使用强度对2型糖尿病患者全因死亡率的影响
Pharmaceuticals (Basel). 2023 Mar 29;16(4):507. doi: 10.3390/ph16040507.
2
Optimal statin use for prevention of sepsis in type 2 diabetes mellitus.他汀类药物在2型糖尿病中预防脓毒症的最佳应用
Diabetol Metab Syndr. 2023 Apr 19;15(1):75. doi: 10.1186/s13098-023-01041-w.
3
Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study.
他汀类药物剂量、类别及使用强度对心血管疾病死亡率一级预防的长期影响：一项全国性2型糖尿病队列研究
Eur J Clin Pharmacol. 2023 May;79(5):687-700. doi: 10.1007/s00228-023-03488-2. Epub 2023 Apr 3.
4
Evaluation of (sdLDLc*HCYc)/HDLc ratio in clinical auxiliary diagnosis of primary cerebral infarction.评估 (sdLDLc*HCYc)/HDLc 比值在原发性脑梗死临床辅助诊断中的价值。
BMC Cardiovasc Disord. 2022 Dec 6;22(1):523. doi: 10.1186/s12872-022-02969-z.
5
Examining the Efficacy of a Very-Low-Carbohydrate Ketogenic Diet on Cardiovascular Health in Adults with Mildly Elevated Low-Density Lipoprotein Cholesterol in an Open-Label Pilot Study.一项开放标签初步研究考察了极低碳水化合物生酮饮食对轻度升高的低密度脂蛋白胆固醇的成年人的心血管健康的功效。
Metab Syndr Relat Disord. 2022 Mar;20(2):94-103. doi: 10.1089/met.2021.0042. Epub 2021 Dec 16.
6
Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis.阿司匹林、非甾体抗炎药及COX-2抑制剂在心血管疾病中的作用：类风湿关节炎治疗中可能的相互作用及影响
Curr Rheumatol Rep. 2004 Oct;6(5):351-6. doi: 10.1007/s11926-004-0009-0.
7
The ALLHAT-LLT and ASCOT-LLA trials: are the discrepancies more apparent than real?抗高血压和降脂治疗预防心脏病发作试验（ALLHAT-LLT）及盎格鲁-斯堪的纳维亚心脏终点试验-降脂治疗（ASCOT-LLA）：这些差异是表象大于实质吗？
Curr Atheroscler Rep. 2004 Jan;6(1):9-11. doi: 10.1007/s11883-004-0110-x.